Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by Sarb99on Feb 10, 2021 2:16pm
160 Views
Post# 32527462

Resaas to bring COVID-19 tests to vacation rentals

Resaas to bring COVID-19 tests to vacation rentals

VANCOUVER, BCFeb. 9, 2021 /CNW/ - RESAAS Services Inc. (TSXV: RSS) (OTCQB: RSASF), a technology platform for the real estate industry, is pleased to announce it has partnered with LMPM, a leading Property Management System, to bring rapid COVID-19 tests to the Vacation Rental Industry.

  • LMPM is a cloud-based, mobile-first enterprise Property Management System (PMS).
  • LMPM is fully integrated with HomeAway/Vrbo, Airbnb (NASDAQ: ABNB), Booking.com (NASDAQ: BKNG), Expedia (NASDAQ: EXPE) & Google (NASDAQ: GOOG).
  • COVID-19 Rapid Tests will be supplied by RESAAS for Property Managers to purchase.
  • The Rapid Tests are FDA authorized, and present results in 8 minutes.

"RESAAS has become the single biggest SaaS Platform for the Real Estate Industry. Adding the ability to buy FDA Authorized COVID-19 Rapid Tests is a fantastic addition to RESAAS' toolkit it offers real estate professionals," said Adrian Barrett, CEO of LMPM. "RESAAS informed us that many Property Managers have purchased rapid test kits directly. LMPM is delighted that it can now offer these kits through RESAAS to the Vacation Rental industry. Being able to offer high-end testing, especially for high-end clients, is a major win for all parties."

LMPM will educate, market and promote the COVID-19 Rapid Tests to their network of Property Managers and Vacation Rental Companies across the United States.

"RESAAS is proud to continue our commitment to enabling all areas of real estate to return to business responsibly," said Tom Rossiter, CEO of RESAAS. "LMPM has developed a best-in-class Property Management System, with a fast-growing following in the Vacation Rental industry. Together, LMPM and RESAAS now offers a solution to enable Property Managers to work with their staff and clients using new safety protocols."

https://www.newswire.ca/news-releases/leading-property-management-system-partners-with-resaas-to-become-first-to-bring-rapid-covid-19-tests-to-vacation-rental-industry-888471063.html  

<< Previous
Bullboard Posts
Next >>